Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-28

Clinical Trial Update: Performance and Safety of I-020805 in Prevention of Cerebrospinal Fluid (CSF) Leakage Following Elective Craniotomy [NA]

View source ↗

Summary

Clinical trial update describing the performance and safety of I-020805 in preventing cerebrospinal fluid leakage after elective craniotomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • I-020805

Snippet

Sponsor: Kuros Biosurgery AG | Conditions: Cerebrospinal Fluid Leakage | NA | Status: COMPLETED